ElectroCore's Vagus Nerve Stimulator Wins Breakthrough Device Tag For Stress Disorder

The FDA has granted Breakthrough Designation to ElectroCore Inc's ECOR gammaCore nVNS device for posttraumatic stress disorder (PTSD).

• The device showed a reduction of symptoms of PTSD by 31% when compared to sham.
• Related: ElectroCore's Non-invasive Nerve Stimulator Effective Against Migraine.
• GammaCore (nVNS) is the first non-invasive, hand-held medical therapy applied at the neck as adjunctive therapy to treat migraine and cluster headache by utilizing a mild electrical stimulation to the vagus nerve passes through the skin. 
• Price Action: ECOR shares are up 20.4% at $0.65 during the market session on the last check Wednesday.